P00797 (RENI_HUMAN) Homo sapiens (Human)

Renin UniProtKBInterProSTRINGInteractive Modelling

406 aa; Sequence (Fasta) ; (Isoform 2); 1 identical sequence: Pan troglodytes: P60016

Available Structures

91 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human prorenin
3vcm
 Heteromer
29-406
1×NAG;
Assess
Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom
6i3f
 Heteromer
P01019; 		69-406
1×NAG; 1×NAG; 10×SO4; 1×GOL;
Assess
Crystal structure of human angiotensinogen complexed with renin
2x0b
 Heteromer
P01019; 		74-406
Assess
Crystal Structure of Human Renin Complexed with Inhibitor
2iko
homo-6-mer69-406
3×7IG;
Assess
Crystal Structure of Human Renin Complexed with Inhibitor
2il2
homo-6-mer69-406
6×LIX; 3×CIT;
Assess
Crystal Structure of Human Renin Complexed with Inhibitors
2iku
homo-6-mer70-406
6×LIY;
Assess
Crystal Structure of Renin with Inhibitor 3
2v16
homo-6-mer70-406
6×C47;
Assess
Crystal structure at 2.6A of human prorenin
4amt
homo-2-mer29-406
2×NAG; 10×SO4;
Assess
HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE …
1hrn
homo-2-mer70-406
2×NAG; 2×03D;
Assess
Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors
3km4
homo-2-mer70-406
1×NAG; 4×22X; 1×NAG;
Assess
Design and optimization of new piperidines as renin inhibitors
3oad
homo-2-mer70-406
1×NAG; 1×LPO;
Assess
Design and optimization of new piperidines as renin inhibitors
3oag
homo-2-mer70-406
1×NAG; 1×LPQ;
Assess
Design and optimisation of new piperidines as renin inhibitors
3o9l
homo-2-mer70-406
1×NAG; 1×LPN;
Assess
CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS
1bil
homo-2-mer70-406
2×0IU;
Assess
CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS
1bim
homo-2-mer70-406
2×0QB;
Assess
Crystal Structure of Renin with Inhibitor 8
2v12
homo-2-mer70-406
2×C39;
Assess
THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITIO…
1rne
homo-2-mer71-406
2×NAG; 2×C60;
Assess
Human renin/PF02342674 complex
2i4q
homo-2-mer72-406
2×UA4;
Assess
Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
3g6z
monomer67-406
1×A7T; 2×NAG;
Assess
Structure-based design of 4-hydroxy-3,5-substituted piperidines as direct renin inhibitors
4q1n
monomer67-406
1×DMS; 1×NAG; 1×PO4; 1×2Y9;
Assess
Human renin in complex with compound2
7xgo
monomer67-406
1×NAG; 1×UNL;
Assess
Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors
3sfc
monomer67-406
1×NAG; 3×GOL; 2×S53;
Assess
Crystal Structure of Renin with Inhibitor 10 (Aliskiren)
2v0z
monomer67-406
1×NAG; 1×C41;
Assess
Human renin in complex with compound1
7xgk
monomer67-406
1×NAG; 1×UNL;
Assess
Crystal structure of renin in complex with NVP-AMQ838 (compound 5)
4gj5
monomer67-406
1×NAG; 1×0LR;
Assess
Crystal structure of renin in complex with NVP-BCH965 (compound 9)
4gjc
monomer67-406
1×NAG; 1×0MJ; 2×SO4;
Assess
Crystal structure of renin in complex with PKF909-724 (compound 3)
4gj8
monomer67-406
1×NAG; 2×0LU; 1×SO4;
Assess
Crystal structure of renin in complex with NVP-AYL747 (compound 5)
4gja
monomer67-406
1×NAG; 1×0M3; 2×SO4;
Assess
Human renin in complex with compound 5
3vuc
monomer67-406
1×NAG; 1×HHE;
Assess
Human renin in complex with compound3
7xgp
monomer67-406
1×NAG; 1×UNL;
Assess
Human renin in complex with inhibitor 7
3vye
monomer67-406
1×NAG; 1×VYE;
Assess
Crystal structure of renin in complex with NVP-BBV031 (compound 6)
4gjb
monomer67-406
1×NAG; 1×0ME; 1×SO4;
Assess
Human renin in complex with compound 18
3vsx
monomer67-406
1×NAG; 1×R32;
Assess
Human renin in complex with inhibitor 9
3vyf
monomer67-406
1×NAG; 1×VYF;
Assess
Human renin in complex with inhibitor 6
3vyd
monomer67-406
1×NAG; 1×VYD;
Assess
Human renin in complex with compound 8
3vsw
monomer67-406
1×NAG; 1×R31;
Assess
Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibi…
5sxn
monomer68-406
1×NAG; 1×74U; 1×PEG;
Assess
Renin in complex with (S)-1-(3-fluoro-5-(((S)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-…
4s1g
monomer68-406
1×NAG; 1×43T;
Assess
Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibi…
5sy2
monomer68-406
1×NAG; 1×74V; 1×PGE; 2×DMS;
Assess
Renin in complex with (4S)-4-isopropyl-4-methyl-6-oxo-1-(3-(2-oxo-4-phenylpyrrolidin-1-yl)benzyl)te…
4xx4
monomer68-406
1×NAG; 1×70Y;
Assess
Renin in complex with (S)-1-(3-(benzylcarbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimid…
4xx3
monomer68-406
1×NAG; 1×70X;
Assess
RENIN IN COMPLEXED WITH 4-methoxy-3-(3-methoxypropoxy)-N-{[(3S,4S)-4-{[(4-methylphenyl)sulfonyl]ami…
4ryc
monomer68-406
1×NAG; 1×3ZK; 1×SO4;
Assess
Crystal structure of renin in complex with NVP-AYZ832 (compound 6a)
4gj6
monomer68-406
1×NAG; 2×0LS; 1×SO4;
Assess
RENIN IN COMPLEXED WITH (3S,4S)-4-({[4-methoxy-3-(3-methoxypropoxy)benzoyl](propan-2-yl)amino}methy…
4rz1
monomer68-406
1×NAG; 1×3ZN; 1×SO4;
Assess
Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors
5t4s
monomer68-406
1×NAG; 1×PG6; 2×DMS;
Assess
RENIN IN COMPLEXED WITH N-({(3S,4S)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3…
4ryg
monomer68-406
1×NAG; 1×3ZJ; 1×SO4;
Assess
Crystal structure of renin in complex with NVP-BGQ311 (compound 12)
4gjd
monomer68-406
1×NAG; 1×0N0; 1×SO4;
Assess
Crystal structure of renin in complex with NVP-BCA079 (compound 12a)
4gj7
monomer68-406
1×NAG; 1×0LT; 1×SO4;
Assess
Crystal structure of renin in complex with GP055321 (compound 4)
4gj9
monomer69-406
1×NAG; 1×0M2;
Assess
Crystal structure of renin in complex with compound4
4pyv
monomer69-406
1×NAG; 1×2XF; 1×DMS; 1×SO4;
Assess
New Classes of Potent and Bioavailable Human Renin Inhibitors
3k1w
monomer70-406
1×BFX; 1×FMT; 1×NAG;
Assess
Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
3g72
monomer70-406
1×DMS; 1×NAG; 1×A6T;
Assess
Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
3g70
monomer70-406
1×A5T; 1×DMS; 1×NAG;
Assess
Crystal structure of human renin complexed with a novel inhibitor
3gw5
monomer70-406
1×NAG; 1×72X; 4×GOL; 1×CL;
Assess
Potent macrocyclic renin inhibitors
3own
monomer70-406
3×ACT; 2×NA; 1×3OX;
Assess
Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
5kot
monomer70-406
1×NAG; 1×6VU; 1×PGE; 3×PEG; 8×DMS;
Assess
Clinically Useful Alkyl Amine Renin Inhibitors
3q5h
monomer70-406
1×NAG; 4×CL; 1×RX6;
Assess
Clinically Useful Alkyl Amine Renin Inhibitors
3q4b
monomer70-406
1×NAG; 4×CL; 1×RX5;
Assess
Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active …
5tmg
monomer70-406
1×NAG; 1×7EK; 1×PGE; 1×PEG; 3×DMS;
Assess
Human renin in complex with remikiren
3d91
monomer70-406
1×REM; 1×DMS;
Assess
Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibi…
5sy3
monomer70-406
1×NAG; 1×74Z; 6×DMS; 1×PEG; 1×1PE;
Assess
Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
5kos
monomer70-406
1×NAG; 1×6VS; 8×DMS; 2×PEG;
Assess
STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RE…
2ren
monomer70-406
1×NAG;
Assess
Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes
3oot
monomer70-406
1×NAG; 1×SSR;
Assess
Alkyl Amine Renin Inhibitors: Filling S1 from S3
3q3t
monomer70-406
1×NAG; 1×RX0; 2×GOL;
Assess
Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol
5v8v
monomer70-406
1×NAG; 2×90D;
Assess
Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active …
5tmk
monomer70-406
1×NAG; 1×7EJ; 3×DMS;
Assess
Crystal Structure Analysis of Renin-indole-piperazine inhibitor complexes
3oqf
monomer70-406
1×NAG; 1×S51;
Assess
Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibi…
5sz9
monomer70-406
1×NAG; 1×74Y; 3×PEG;
Assess
Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol
5vpm
monomer70-406
1×NAG; 1×9G7; 1×SO4;
Assess
Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes
3oqk
monomer70-406
1×NAG; 1×S52;
Assess
Crystal Structure of Renin with Inhibitor 9
2v10
monomer70-406
1×C61;
Assess
Crystal Structure of Renin with Inhibitor 6
2v11
monomer70-406
1×C80;
Assess
Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol
5vrp
monomer70-406
1×NAG; 1×SO4; 2×9JD;
Assess
Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
5koq
monomer71-406
1×NAG; 1×6VR;
Assess
Crystal Structure of Renin with Inhibitor 7
2v13
monomer71-406
1×C40;
Assess
X-RAY ANALYSES OF PEPTIDE INHIBITOR COMPLEXES DEFINE THE STRUCTURAL BASIS OF SPECIFICITY FOR HUMAN …
1bbs
monomer72-406
Assess
crystal structure of renin-pf00257567 complex
2bkt
monomer73-406
1×RPF;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g24
monomer74-406
1×7IG;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g26
monomer74-406
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g21
monomer74-406
1×L1B;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the C ring
2fs4
monomer74-406
Assess
crystal structure of Renin-PF00074777 complex
2bks
monomer74-406
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring
2g20
monomer74-406
1×L1A;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring
2g1r
monomer74-406
1×NAG; 1×3IG;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g1y
monomer74-406
1×NAG; 1×5IG;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g22
monomer74-406
1×NAG; 1×6IG;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring
2g1s
monomer74-406
1×NAG; 1×4IG;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g1o
monomer74-406
1×NAG; 1×2IG;
Assess
Ketopiperazine-based renin inhibitors: Optimization of the "C" ring
2g1n
monomer74-406
1×NAG; 1×1IG;
Assess
Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2g27
monomer74-406
1×4LG;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2x0b.1.Amonomer0.9074-406
100.00
Assess
4amt.1.Amonomer0.7829-406
100.00
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22x0b.1.Amonomer0.9074-403
99.47
Assess
Isoform 24amt.1.Amonomer0.7829-403
100.00
Assess